October 14th 2024, 7:00pm
TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.
October 11th 2024, 9:00pm
Removing more lymph nodes during surgery may also increase the risk for death after surgery in muscle-invasive bladder cancer.
October 11th 2024, 5:00pm
After my surgery for testicular cancer, my good friend Joe helped me through my goal of training and running a marathon.
October 8th 2024, 5:00pm
Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a helpful tool.
October 4th 2024, 9:00pm
Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.
October 1st 2024, 1:00pm
Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic kidney cancer.
September 27th 2024, 7:00pm
An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.
September 27th 2024, 1:00pm
The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
September 26th 2024, 3:00pm
An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.
September 24th 2024, 7:00pm
An expert provides answers to pressing questions regarding different aspects of a kidney cancer journey, including stage, grade and treatment options.
Understanding Lung Cancer Trial Results and Their Treatment Impact
He Preached Early Detection; Then It Saved His Life
FDA Approves Inluriyo for ER+, HER2– Metastatic Breast Cancer
A Day in the Life: Growing Where I’m Planted